Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTarsus Regulatory News (TRS)

  • There is currently no data for TRS

Interim Management Statement

10 May 2010 07:00

RNS Number : 5791L
Tarsus Group PLC
10 May 2010
 



 

 

 

TARSUS GROUP plc

 

Interim Management Statement

 

Tarsus Group Plc ("Tarsus" or "the Group"), the international business-to-business media group, is today publishing its Interim Management Statement relating to the period from the publication of its Preliminary Results on 8 March 2010 to 9 May 2010.

 

Trading Performance

 

Trading for the period has been in line with the Board's expectations. A summary of major developments includes:

 

§ US - continued recovery & momentum

 

The Medical division continues to gain momentum. The April Orlando event produced revenues well ahead of last year, driven by very strong growth from its education programmes. Exhibition and conference revenues also grew for the first time in 18 months.

 

§ France - management action retains margins within expectations

 

A number of small exhibitions have taken place in France since 8 March. As expected, the declining revenue trends experienced in the second half of 2009 have continued into the first half of 2010. Strong cost management has resulted in margins remaining within our expectations.

 

§ Emerging Markets

 

No material events have taken place since 8 March.

 

Financial Position

 

There have been no significant changes to the financial position of the Group since the publication of the Preliminary Results on 8 March 2010.

 

Outlook

 

At our preliminary results at the start of March we announced the launch of "Project 50/13" to accelerate our scale in Emerging Markets. Our business infrastructure in the region is now established and Tarsus has a much improved platform within Asia and the Middle East from which to continue to drive strong growth.

 

As in previous years, the Group's revenues remain heavily second-half weighted and, overall, forward bookings remain at a similar level to 2009.

 

The French portfolio is weighted towards the 4th quarter of the year and we are now seeing signs of stabilisation in that market, with forward bookings for 4th quarter events at similar levels to last year. Given the current economic outlook for Europe, we continue to remain cautious.

 

US sales are strong and ahead of 2009, driven mainly by our Off-Price (discount clothing) and Medical divisions. Labelexpo America's sales are marginally behind the previous edition, owing to smaller exhibitors booking later in the cycle.

 

In the Emerging Markets division, the Group's largest event this year is MEBA (business aviation) which takes place in Dubai for which forward bookings are well ahead of the previous cycle.

 

Our view of trading for 2010 is unchanged with long term exhibition trends intact. The recovery in the US economy is benefiting our business in that market and we are seeing good growth prospects and opportunities in Emerging Markets. Our strong brands, diversified portfolio of market leading events and increased focus on Emerging Markets leave Tarsus well positioned for the future.

 

Tarsus Group plc:

 

Douglas Emslie, Group Managing Director 020 8846 2700

Ashley Milton, Group Finance Director 020 8846 2700

 

Media:

 

Madano Partnership

Matthew Moth 020 7593 4000

 

Investors/Analysts:

 

IRfocus

Neville Harris 020 7593 4015

 

Scott Harris

Stephen Scott, Jeremy Wiseman 020 7653 0030

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSKKODKABKDOPK
Date   Source Headline
30th Mar 20122:53 pmRNSAcquisition of Life Media
30th Mar 201211:53 amRNSTotal Voting Rights
28th Mar 20124:58 pmRNSHolding(s) in Company
27th Mar 20125:23 pmRNSHolding(s) in Company
27th Mar 20125:22 pmRNSDirector/PDMR Shareholding
26th Mar 20123:33 pmRNSHolding(s) in Company
23rd Mar 20124:25 pmRNSHolding(s) in Company
23rd Mar 20128:05 amRNSAdmission of Placing Shares
20th Mar 20127:00 amRNSAcquisition and Placing
7th Mar 20127:00 amRNSFinal Results
27th Feb 201210:00 amRNSChange of time for results presentation
31st Jan 20125:00 pmRNSTotal Voting Rights
27th Jan 20123:00 pmRNSNotice of Results
19th Jan 201212:00 pmRNSApplication for Admission
5th Jan 20127:00 amRNSTrading Update
20th Dec 20119:00 amRNSScrip Dividend Circular
5th Dec 201110:23 amRNSCompletion of Disposal
28th Nov 20111:09 pmRNSResult of EGM
17th Nov 20117:00 amRNSInterim Management Statement
9th Nov 20115:22 pmRNSBlocklisting Interim Review
7th Nov 20114:30 pmRNSDisposal of ModAmont SAS - posting of circular
3rd Oct 20117:00 amRNSTrading Statement
26th Aug 20117:00 amRNSInterim Financial Statements 2011
8th Aug 20112:56 pmRNSDirector/PDMR Shareholding
29th Jul 20115:48 pmRNSTotal Voting Rights
29th Jul 20114:07 pmRNSDirector/PDMR Shareholding
8th Jul 20111:39 pmRNSApplication for Admission
5th Jul 20114:52 pmRNSHolding(s) in Company
30th Jun 20114:00 pmRNSTotal Voting Rights
30th Jun 20117:00 amRNSPre-close Trading Statement
20th Jun 20115:36 pmRNSDirector/PDMR Shareholding
17th Jun 20112:17 pmRNSResult of AGM
9th Jun 20115:45 pmRNSScrip dividend circular
9th Jun 20115:44 pmRNSHolding(s) in Company
9th Jun 20115:41 pmRNSHolding(s) in Company
9th Jun 20115:39 pmRNSHolding(s) in Company
9th Jun 20115:37 pmRNSHolding(s) in Company
7th Jun 20118:05 amRNSAcquisition of IFO and Total Voting Rights
6th Jun 20113:49 pmRNSResult of EGM
1st Jun 20115:14 pmRNSApplication for Admission
24th May 20115:32 pmRNSHolding(s) in Company
20th May 20114:31 pmRNSAnnual Information Update
19th May 20117:00 amRNSPlacing and Acquisition
9th May 20115:00 pmRNSBlocklisting Interim Review
5th May 20117:00 amRNSDirectorate Change
5th May 20117:00 amRNSInterim Management Statement
4th May 20117:00 amRNSNotice of Interim Management Statement
28th Apr 20113:42 pmRNSTotal Voting Rights
19th Apr 20117:00 amRNSAnnual Report & Accounts
31st Mar 20113:46 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.